SCHEMBL23504656

SCHEMBL23504656

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc(-c6cccc7oc8ccccc8c67)cc5)c5oc6ccccc6c45)c4ccccc34)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.41
▸ CDC14A Q9UNH5 2/20 0.41
▸ ALOX5 P09917 2/20 0.40
▸ BACE1 P56817 1/20 0.36
▸ TDP1 Q9NUW8 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ ENPP3 O14638 1/20 0.35
▸ ENPP1 P22413 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23504605 0.96 CDC14B (0.39) CDC14BCDC14AALOX5BACE1TDP1
SCHEMBL22952683 0.93 CDC14B (0.46) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL23504517 0.92 ALOX5 (0.41) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL22707604 0.92 CDC14B (0.42) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL24174592 0.92 CDC14B (0.42) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL23504597 0.91 ALOX5 (0.48) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL18382883 0.91 ALOX5 (0.40) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL23504604 0.91 ALOX5 (0.40) CDC14BCDC14AALOX5TDP1L3MBTL1
SCHEMBL18382889 0.90 CDC14B (0.39) CDC14BCDC14AALOX5TDP1KDM4E
SCHEMBL23504692 0.89 CDC14B (0.45) CDC14BCDC14AALOX5BACE1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11038123-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2021-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11038123-B2 Compound and organic electronic device using the same CHRM1, CHRM2, C1S CDC14B 3827/4885CDC14A 3754/4885ALOX5 3207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback